Sökning: WFRF:(Yvan Charvet L)
> (2017) >
Can LDL cholesterol...
Can LDL cholesterol be too low? Possible risks of extremely low levels
-
- Olsson, Anders, 1940- (författare)
- Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Endokrinmedicinska kliniken
-
- Angelin, B. (författare)
- Karolinska Institutet
-
- Assmann, G. (författare)
- University of Munster, Germany
-
visa fler...
-
- Binder, C. J. (författare)
- Medical University of Vienna, Austria; Austrian Academic Science, Austria
-
- Bjoerkhem, I. (författare)
- Karolinska Institutet
-
- Cedazo-Minguez, A. (författare)
- Karolinska Institutet
-
- Cohen, J. (författare)
- UTSouthwesternMedical Centre, TX USA
-
- von Eckardstein, A. (författare)
- University of Zurich, Switzerland
-
- Farinaro, E. (författare)
- University of Naples Federico II, Italy
-
- Mueller-Wieland, D. (författare)
- University of Cologne, Germany
-
- Parhofer, K. G. (författare)
- Ludwig Maximilians University of Munchen, Germany
-
- Parini, P. (författare)
- Karolinska Institutet
-
- Rosenson, R. S. (författare)
- Mt Sinai Hospital, NY 10029 USA
-
- Starup-Linde, J. (författare)
- University of Aarhus, Denmark
-
- Tikkanen, M. J. (författare)
- University of Helsinki, Finland
-
- Yvan-Charvet, L. (författare)
- University of Nice Sophia Antipolis, France
-
visa färre...
-
(creator_code:org_t)
- 2017-05-18
- 2017
- Engelska.
-
Ingår i: Journal of Internal Medicine. - : WILEY. - 0954-6820 .- 1365-2796. ; 281:6, s. 534-553
- Relaterad länk:
-
https://onlinelibrar...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Following the continuous accumulation of evidence supporting the beneficial role of reducing low-density lipoprotein cholesterol (LDL-C) levels in the treatment and prevention of atherosclerotic cardiovascular disease and its complications, therapeutic possibilities now exist to lower LDL-C to very low levels, similar to or even lower than those seen in newborns and nonhuman species. In addition to the important task of evaluating potential side effects of such treatments, the question arises whether extremely low LDL-C levels per se may provoke adverse effects in humans. In this review, we summarize information from studies of human cellular and organ physiology, phenotypic characterization of rare genetic diseases of lipid metabolism, and experience from clinical trials. Specifically, we emphasize the importance of the robustness of the regulatory systems that maintain balanced fluxes and levels of cholesterol at both cellular and organismal levels. Even at extremely low LDL-C levels, critical capacities of steroid hormone and bile acid production are preserved, and the presence of a cholesterol blood-brain barrier protects cells in the central nervous system. Apparent relationships sometimes reported between less pronounced low LDL-C levels and disease states such as cancer, depression, infectious disease and others can generally be explained as secondary phenomena. Drug-related side effects including an increased propensity for development of type 2 diabetes occur during statin treatment, whilst further evaluation of more potent LDL-lowering treatments such as PCSK9 inhibitors is needed. Experience from the recently reported and ongoing large event-driven trials are of great interest, and further evaluation including careful analysis of cognitive functions will be important. This is an article from the symposium: Risks and benefits of Extremely Low LDL Cholesterol.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Annan klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Other Clinical Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
Nyckelord
- abetalipoproteinaemia; adverse effects; hypocholesterolaemia; low-density lipoprotein; safety
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Olsson, Anders, ...
-
Angelin, B.
-
Assmann, G.
-
Binder, C. J.
-
Bjoerkhem, I.
-
Cedazo-Minguez, ...
-
visa fler...
-
Cohen, J.
-
von Eckardstein, ...
-
Farinaro, E.
-
Mueller-Wieland, ...
-
Parhofer, K. G.
-
Parini, P.
-
Rosenson, R. S.
-
Starup-Linde, J.
-
Tikkanen, M. J.
-
Yvan-Charvet, L.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Annan klinisk me ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Cell och molekyl ...
- Artiklar i publikationen
-
Journal of Inter ...
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet